Atlas Trials

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

Clinical trial NCT03710421 · SUSPENDED

Trial details

NCT number
NCT03710421
Sponsor
City of Hope Medical Center
Status
SUSPENDED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Start date
2019-04-23
Primary completion
2027-02-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.